会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Aralkyl diazabicycloalkane derivatives for CNS disorders
    • 用于CNS病症的芳烷基二氮杂双环烷烃衍生物
    • US5679679A
    • 1997-10-21
    • US348654
    • 1994-12-02
    • Wayne BowenBrian R. de CostaCelia DominguezXiao-Shu HeKenner C. Rice
    • Wayne BowenBrian R. de CostaCelia DominguezXiao-Shu HeKenner C. Rice
    • A61K31/495C07D471/04C07D487/04C07D31/495C07D31/55
    • C07D471/04A61K31/495C07D487/04
    • Certain aralkyl diazabicyloalkyl compounds are described for treatment of CNS disorders such as cerebral ischemia, psychoses and convulsions. Compounds of particular interest are of the formula: ##STR1## wherein: each of R.sup.1, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 is independently selected from the group consisting of hydrido, loweralkyl, benzyl and haloloweralkyl; each of R.sup.2, R.sup.3, and R.sup.8 through R.sup.11 is independently selected from the group consisting of hydrido, hydroxy, loweralkyl, benzyl, phenoxy, benzyloxy and haloloweralkyl; n is an integer of from three to four; m is an integer of two; A is selected from the group consisting of phenyl, naphthyl, benzothienyl, benzofuranyl and thienyl and wherein any of the foregoing A groups can be further substituted with one or more substituents independently selected from the group consisting of hydrido, hydroxy, loweralkyl, loweralkoxy, halo, haloloweralkyl, amino, monoloweralkylamino and diloweralkylamino; or a pharmaceutically acceptable salt thereof.
    • 描述了某些芳烷基二氮杂双环烷基化合物用于治疗中枢神经系统疾病如脑缺血,精神病和抽搐。 特别感兴趣的化合物具有下式:其中:R 1,R 4,R 5,R 6和R 7各自独立地选自氢,低级烷基,苄基和卤代低级烷基; R 2,R 3和R 8至R 11各自独立地选自氢,羟基,低级烷基,苄基,苯氧基,苄氧基和卤代低级烷基; n是3至4的整数; m是2的整数; A选自苯基,萘基,苯并噻吩基,苯并呋喃基和噻吩基,其中任何前述A基团可以进一步被一个或多个独立地选自羟基,羟基,低级烷基,低级烷氧基,卤代 ,卤代低级烷基,氨基,单低级烷基氨基和二低级烷基氨基; 或其药学上可接受的盐。
    • 4. 发明授权
    • Aralkyl bridged diazabicycloalkane derivatives for CNS disorders
    • 用于CNS病症的芳烷基桥连二氮杂双环烷烃衍生物
    • US5679673A
    • 1997-10-21
    • US344304
    • 1994-11-21
    • Wayne BowenBrian R. de CostaCelia DominguezXiao-Shu HeKenner C. Rice
    • Wayne BowenBrian R. de CostaCelia DominguezXiao-Shu HeKenner C. Rice
    • C07D453/02C07D487/08A61K31/55C07D471/08
    • C07D487/08C07D453/02
    • Certain aralkyl diazabicycloalkyl compounds are described for treatment of CNS disorders such as cerebral ischemia, psychoses and convulsions. Compounds of particular interest are of the formula: ##STR1## wherein each of R, R.sup.1, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 is independently selected from hydrido, lower-alkyl, benzyl, and haloloweralkyl; wherein each of R.sup.2, R.sup.3 and R.sup.10 through R.sup.13 is independently selected from hydrido, hydroxy, loweralkyl, benzyl, phenoxy, benzyloxy and haloloweralkyl; wherein each of R.sup.8 and R.sup.9 is selected from hydrido, loweralkyl, benzyl and haloloweralkyl; wherein m is an integer of from two to four; wherein A is selected from phenyl, naphthyl, benzothiophenyl, benzofuranyl and thienyl; wherein any of the foregoing A groups can be further substituted with one or more substituents independently selected from hydrido, hydroxy, loweralkyl, loweralkoxy, halo, haloloweralkyl, amino, monoloweralkylamino and diloweralkylamino; or a pharmaceutically acceptable salt thereof.
    • 描述了某些芳烷基二氮杂双环烷基化合物用于治疗中枢神经系统疾病如脑缺血,精神病和抽搐。 特别感兴趣的化合物具有下式:其中R,R 1,R 4,R 5,R 6和R 7各自独立地选自氢,低级烷基,苄基和卤代低级烷基; 其中R2,R3和R10至R13各自独立地选自氢,羟基,低级烷基,苄基,苯氧基,苄氧基和卤代低级烷基; 其中R8和R9各自选自氢,低级烷基,苄基和卤代低级烷基; 其中m是2至4的整数; 其中A选自苯基,萘基,苯并噻吩基,苯并呋喃基和噻吩基; 其中前述A基团中的任一个可以进一步被一个或多个独立地选自氢,羟基,低级烷基,低级烷氧基,卤素,卤代低级烷基,氨基,单低级烷基氨基和二低级烷基氨基的取代基取代。 或其药学上可接受的盐。
    • 7. 发明授权
    • Aralkyl diazabicycloalkane derivatives for CNS disorders
    • 用于CNS病症的芳烷基二氮杂双环烷烃衍生物
    • US5958920A
    • 1999-09-28
    • US954284
    • 1997-10-20
    • Wayne BowenBrian R. de CostaCelia DominguezXiao-Shu HeKenner C. Rice
    • Wayne BowenBrian R. de CostaCelia DominguezXiao-Shu HeKenner C. Rice
    • A61K31/495C07D471/04C07D487/04C07D31/495C07D31/55
    • C07D471/04A61K31/495C07D487/04
    • Certain aralkyl diazabicycloalkyl compounds are disclosed for treatment of CNS disorders, such as cerebral ischemia, psychosis and convulsions. Compounds of particular interest are of the formula: ##STR1## wherein m is three or four; wherein z is selected from the group consisting of ##STR2## wherein when Z is ##STR3## n and p are integers of from one to four, with a sum of four or five, and when Z is ##STR4## n and p are integers of from one to three, with a sum of three or four; wherein A is selected from the group consisting of aryl, heteroaryl, aryloxy, heteroaryloxy, aralkoxy, heteroaralkoxy, arylamino, heteroarylamino, aralkylamino, heteroaralkylamino, arylthio, heteroarylthio, aralkylthio, and heteroaralkylthio; wherein any of the foregoing A groups can be further substituted with one or more substituents independently selected from the group consisting of hydrido, hydroxy, alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, aryl, alkoxy, aryloxy, aralkoxy, alkoxyalkyl, halo, haloalkyl, hydroxyalkyl, cyano, amino, monoalkylamino, dialkylamino, carboxy, carboxyalkyl, alkanoyl, alkenyl and alkynyl; or a pharmaceutically acceptable salt thereof.
    • 公开了某些芳烷基二氮杂双环烷基化合物用于治疗中枢神经系统疾病,如脑缺血,精神病和抽搐。 特别感兴趣的化合物具有下式:其中m为三或四; 其中z选自其中当Z为n且p为1至4的整数时,其总数为4或5,当Z为n且p为1至3的整数时,其总和为 三或四; 其中A选自芳基,杂芳基,芳氧基,杂芳氧基,芳烷氧基,杂芳烷氧基,芳基氨基,杂芳基氨基,芳烷基氨基,杂芳烷基氨基,芳硫基,杂芳硫基,芳烷硫基和杂芳烷硫基。 其中前述A基团中的任一个可以进一步被一个或多个独立地选自羟基,羟基,烷基,环烷基,环烷基烷基,芳烷基,芳基,烷氧基,芳氧基,芳烷氧基,烷氧基烷基,卤素,卤代烷基, ,氰基,氨基,单烷基氨基,二烷基氨基,羧基,羧基烷基,烷酰基,烯基和炔基; 或其药学上可接受的盐。